Search clinical trials for: High dose HB-101

Total 1921 results

Boehringer Ingelheim
Eli Lilly and Company

Completed

A 16 Weeks Study on Efficacy and Safety of Two Doses of Empagliflozin (BI 10773) (Once Daily Versus Twice Daily) in Patients With Type 2 Diabetes Mellitus and Preexisting Metformin Therapy

Diabetes Mellitus, Type 2

United States, Australia, Canada, Estonia, France, Georgia, Germany, Guatemala, Italy, Latvia, Lithuania, Mexico, New Zealand, Poland, Russian Federation, South Africa, Spain, Ukraine
Pfizer

Completed

A Study to Evaluate the Effect of Hepatic Impairment on the Pharmacokinetics of Glasdegib

Hepatic Impairment

United States
Idorsia Pharmaceuticals Ltd.

Terminated

A Study in Healthy Subjects to Investigate the Safety and Tolerability of ACT- 541478 as Well as What ACT-541478 Does to the Body and the Way the Body Takes up, Distributes, and Gets Rid of ACT-541478

Healthy

Germany
Bioprojet

Completed

Randomized Clinical Trial Evaluating BP1.3656 Versus Placebo For Alcohol Use Disorder Treatment

Alcohol Use Disorder

France, Bulgaria, Russian Federation
Guangzhou Patronus Biotech Co., Ltd.
Yantai Patronus Biotech Co., Ltd.

Active, not recruiting

Safety and Immunogenicity of COVID-19 Vaccine in Population Aged 18 Years and Above

COVID-19

China
Medical University of Graz

Terminated

High-dose Vitamin D3 in Pancreas Cancer (VITdCUT)

Quality of Life | Vitamin D Deficiency | Pancreas Cancer

Austria
Richard H. Haas
Thrasher Research Fund

Completed

Pharmacokinetic and Safety Trial of Intravenous Levetiracetam in the Treatment of Neonatal Seizures (Keppra)

Seizures | Disorder of Fetus or Newborn

United States
Affiris AG
Medical University Innsbruck; Forschungszentrum Juelich; PROSENEX AmbulatoriumbetriebsGMBH

Completed

Study Assessing Tolerability and Safety of AFFITOPE® PD03A in Patients With Early Parkinson's Disease (AFF011)

Parkinson Disease | Neurodegenerative Diseases

Austria
University of Oxford

Completed

Safety and Immunogenicity Study of Three Candidate HIV-1 Vaccines, Administered in Combination to Healthy HIV-1 Uninfected Adults (HIV-CORE 002)

HIV-1 Infections

United Kingdom
Oyster Point Pharma, Inc.

Completed

Clinical Trial to Evaluate the Efficacy of OC-02 Nasal Spray on Signs and Symptoms of Dry Eye Disease (The PEARL Study)

Dry Eye Disease

United States
M.D. Anderson Cancer Center

Recruiting

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

Melanoma | Pancreatic Cancer | Cholangiocarcinoma Metastatic | Liver Malignant Tumors

United States
National Institute of Allergy and Infectious Diseases...

Completed

Systems Analyses of the Immune Response to the Seasonal Influenza Vaccine

Healthy Volunteer

United States
Shanghai General Hospital, Shanghai Jiao Tong University...

Unknown

High-dose Intensity Modulated Radiotherapy and Concurrent Chemotherapy in Esophageal Cancer

Esophageal Cancer

China
Stoke Therapeutics, Inc

Completed

An Open-Label Study to Investigate the Safety of Single and Multiple Ascending Doses in Children and Adolescents With Dravet Syndrome

Dravet Syndrome

United States
Terence Flotte
Massachusetts General Hospital; University of Massachusetts, Worcester

Active, not recruiting

A Dose-escalation and Safety & Efficacy Study of AXO-AAV-GM2 in Tay-Sachs or Sandhoff Disease

Tay-Sachs Disease | Sandhoff Disease

United States
Duke University
Boston Medical Center; Centers for Disease Control and Prevention; Children's...

Completed

FLUAD® vs. Fluzone® High-Dose Study

Quality of Life | Pain | Adverse Drug Event | Injection Site Reaction | Side Effect of Drug

United States
Sanofi Pasteur, a Sanofi Company

Completed

Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2020-2021 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Healthy Volunteers | Influenza Immunization

United States
Merck Sharp & Dohme LLC

Completed

A Study to Evaluate the Safety, Tolerability and Immunogenicity of V114 in Healthy Adults and Infants (V114-005)

Pneumococcal Infections
Vaxart

Completed

Dose-Ranging Trial of Safety & Immunogenicity of an Oral Adenoviral-Vector Based RSV Vaccine (VXA-RSV-f)

Respiratory Syncytial Virus (RSV)

United States
Boehringer Ingelheim

Completed

A Study in Healthy People to Measure the Amount of BI 655130 in the Blood After Injecting Different Doses Into Different Parts of the Body

Healthy

Belgium
Supernus Pharmaceuticals, Inc.

Completed

Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD

Attention-Deficit/Hyperactivity Disorder (ADHD)

United States
National Institute of Allergy and Infectious Diseases...
Autoimmunity Centers of Excellence

Terminated

Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus

Systemic Lupus Erythematosus

United States
Sanofi Pasteur, a Sanofi Company

Completed

Annual Study for Collection of Serum Samples in Children and Older Adults Receiving the 2021-2022 Formulations of Fluzone Quadrivalent Vaccine and Fluzone High-Dose Quadrivalent Vaccine, Respectively

Healthy Volunteers | Influenza Immunization

United States
Sinovac Research and Development Co., Ltd.

Suspended

Immunogenicity and Safety Study of the 3rd Booster Dose Using the High or Medium Dose of Inactivated (CoronaVac®) Vaccine in Healthy Adults in Turkey

COVID-19

Turkey
Basilea Pharmaceutica
ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...

Completed

Phase 1/2 Study of Derazantinib (ARQ 087) in Adult Subjects With Advanced Solid Tumors With FGFR Genetic Alterations

Solid Tumor

United States, Italy
Memorial Sloan Kettering Cancer Center
GlaxoSmithKline

Completed

Sequential Chemo-Radioimmunotherapy Followed by Autologous Transplantation for Patients With Untreated Advanced Stage Mantle Cell Lymphoma

Mantle Cell Lymphoma

United States
Altimmune, Inc.

Completed

Study of the Safety and Immunogenicity of NasoVAX Extension

Influenza

United States
Bassett Healthcare
New York State Department of Health

Completed

Duration of Immune Response to Influenza Vaccination in Patients With RA

Rheumatoid Arthritis

United States
Merck Sharp & Dohme LLC

Completed

Safety and Efficacy Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis (P08648)

Seasonal Allergic Rhinitis
Boehringer Ingelheim

Completed

Effect of Treatment With BIIL 284 BS on Exercise Endurance in Patients With Chronic Obstructive Pulmonary Disease

Pulmonary Disease, Chronic Obstructive
NewLink Genetics Corporation

Withdrawn

Efficacy Study of Maintenance IT-101 Therapy for Ovarian Cancer Patients.

Cancer | Ovarian Cancer | Solid Tumor

United States
AC Immune SA
National Institute on Aging (NIA); Alzheimer's Disease Cooperative Study (ADCS) and other collaborators

Completed

Safety, Tolerability and Immunogenicity of ACI-24 Vaccine in Adults With Down Syndrome (3-Star)

Down Syndrome

United States
USDA Grand Forks Human Nutrition Research Center

Completed

Motivation to Exercise (Motiv2Ex)

Obesity | Overweight | Physical Activity

United States
National Institute of Allergy and Infectious Diseases...
Consortium of Food Allergy Research

Completed

Peanut Epicutaneous Phase II Immunotherapy Clinical Trial

Hypersensitivity | Food Hypersensitivity | Hypersensitivity, Immediate | Peanut Hypersensitivity

United States
Ingredia S.A.

Completed

Investigation of Milk Peptides on Postprandial Blood Glucose Profile

Postprandial Hyperglycemia

Germany
Hocheol Kim

Completed

Clinical Trial to Assess the Efficacy and to Evaluate Safety of HT047 in Patients With Acute Ischemic Stroke

Ischemic Stroke

Korea, Republic of
Boehringer Ingelheim

Completed

Multiple Dose Comparison of the Effect of Two Dose Combinations of Tipranavir/Ritonavir (TPV/RTV), on the Pharmacokinetic Characteristics of Efavirenz (Sustiva®) in Healthy Adult Volunteers

Healthy
Seoul National University Hospital
DongGuk University

Unknown

Effect of Ginseol Kg1 on Blood Pressure Lowering

Prehypertension | Hypertension, Stage I

Korea, Republic of
Dalin Tzu Chi General Hospital

Recruiting

Effects of Herbal Sleep Formula on Patients With Insomnia and Tinnitus

Tinnitus | Sleep Disturbances

Taiwan
Boehringer Ingelheim

Completed

Japanese Pegylated Interferon (PegIFN) Alfa-2b/Ribavirin (RBV) Combination Trial

Hepatitis C

Japan
University of Alabama at Birmingham

Recruiting

B Cell and Antibody Response to Seasonal Influenza Vaccines in Younger and Older Adults

Influenza

United States
GlaxoSmithKline

Completed

A Study to Assess the Safety, Reactogenicity and Immune Response of GlaxoSmithKline (GSK) Biologicals' Investigational Respiratory Syncytial Virus (RSV) Vaccine (GSK3844766A) in Older Adults

Respiratory Syncytial Virus Infections

United States, Belgium
Baylor College of Medicine

Recruiting

High Dose Albumin in Refractory Ascites

Ascites

United States
Jhpiego
Bill and Melinda Gates Foundation

Completed

Accelerating Newborn Survival in Ghana Through a Low-dose, High-frequency Health Worker Training Approach

Stillbirth | Neonatal Death
Memorial Sloan Kettering Cancer Center

Completed

High Dose Rate Prostate Brachytherapy as Salvage for Locally Recurrent Prostate Cancer Previously Treated With External Beam Radiotherapy

Prostate Cancer

United States
Vertex Pharmaceuticals Incorporated

Completed

Evaluation of Efficacy and Safety of VX-548 for Acute Pain After a Bunionectomy

Acute Pain

United States
ViGenCell Inc.

Not yet recruiting

A Prospective, Open Label, Dose-escalation, SAD/MAD, Multicenter, 24weeks, Phase I/IIa Clinical Trial to Evaluate the Safety, Tolerability and Pharmacodynamics of Investigational Product (VM-001) in Patients With Graft-versus-host Disease(GvHD)

Graft Versus Host Disease
reMYND

Recruiting

A Phase 2a Study to Investigate REM0046127 in Mild to Moderate Alzheimer's Disease

Alzheimer Disease

Netherlands, Spain
Universidad Católica San Antonio de Murcia

Completed

Study to Analyze the Efficacy of Acute Intake With a β-alanine Supplement in Recreational Cyclists (B-AC1)

Beta Alanine Supplementation

Spain
Zucara Therapeutics Inc.

Terminated

Effect of ZT-01 on Glucagon During Hypoglycemia in Type 1 Diabetes Mellitus

Hypoglycemia | Type 1 Diabetes

Canada

3

Subscribe